leading pharmaceutical glp-1 treatments How medications are transforming diabetes and weight loss treatment resveratrol. Who are the leading innovators

Nurses This activity awards 1.50 Nursing contact hours

Readers should consult FDA.gov for the most current regulatory status

Many patients taking GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) report altered taste experiences during treatment

However, severe or prolonged diarrhea can lead to dehydration and electrolyte imbalances, which require medical attention

Discussions The results of this study showed that the 7 GLP-1RAs were ranked from highest to lowest as semaglutide, dulaglutide, liraglutide, exenatide, lixisenatide, PEG loxenatide, and benalutide

In rats, the drugs, known as glucagon-like-peptide-1 (GLP-1) receptor agonists, have been shown to cause thyroid C-cell tumors